# GISEL:Registry of Breast Cancer Patients Treated With ECT

> **NCT06683404** · — · COMPLETED · sponsor: **Istituto Oncologico Veneto IRCCS** · enrollment: 205 (actual)

## Conditions studied

- Breast Cancer
- Breast Cancer Metastatic
- Breast Cancer Recurrent

## Interventions

- **DEVICE:** Electrochemotherapy (ECT)
- **DRUG:** Bleomycin

## Key facts

- **NCT ID:** NCT06683404
- **Lead sponsor:** Istituto Oncologico Veneto IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-22
- **Primary completion:** 2021-10-21
- **Final completion:** 2022-12-10
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06683404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06683404, "GISEL:Registry of Breast Cancer Patients Treated With ECT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06683404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*